Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadeqately controlled type 2 diabetes mellitus: a randomized controlled trial
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 김동선 | - |
| dc.date.accessioned | 2021-08-03T00:28:00Z | - |
| dc.date.available | 2021-08-03T00:28:00Z | - |
| dc.date.issued | 2017-09-30 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/31199 | - |
| dc.title | Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadeqately controlled type 2 diabetes mellitus: a randomized controlled trial | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 2017 International Conference on Diabetes and Metabolosm | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 서울 의과대학 > 서울 내과학교실 > 2. Conference Papers
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.